Ann Gastroenterol. 2020 May-Jun;33(3):250-256. doi: 10.20524/aog.2020.0475. Epub 2020 Apr 02.
The impact of risk factors on gastroparesis at an urban medical center.
Annals of gastroenterology
Katherine Duffey, Michelle Hannon, Joseph Yoo, Nicholas Perkons, Charles Intenzo, Stephanie Moleski, Anthony J DiMarino
Affiliations
Affiliations
- Department of Medicine, Division of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA (Katherine Duffey, Michelle Hannon).
- Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA (Joseph Yoo, Stephanie Moleski, Anthony J. DiMarino).
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (Nicholas Perkons).
- Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Thomas Jefferson University, Philadelphia, PA (Charles Intenzo), USA.
PMID: 32382227
PMCID: PMC7196617 DOI: 10.20524/aog.2020.0475
Abstract
BACKGROUND: Gastroparesis is a complex and poorly understood disease. The literature is lacking with respect to the epidemiology of patient comorbidities and their effect on gastric emptying. We aimed to describe the most common comorbid conditions among patients with gastroparesis in an urban population and quantify the effect of these comorbidities on the severity of delayed gastric emptying (DGE).
METHODS: We examined the medical records of all patients diagnosed with gastroparesis at a quaternary care center between 2014 and 2015. The severity of DGE was analyzed after patients were stratified for possible causative etiologies. Likelihood ratio tests were used to assess the significance of demographic and scintigraphic variation in this population.
RESULTS: Of the 221 patients, 56.1% were Caucasian and 31.7% were African American. Among these patients, 29.4% had evidence of medication-associated gastroparesis, 29.0% had diabetes-associated gastroparesis, and 31.7% had idiopathic disease. African American patients with gastroparesis were more likely to have diabetic gastroparesis than patients of other races (P=0.01). There was a statistically significant relationship between the number of major risk factors and the severity of a patient's DGE (P=0.004).
CONCLUSIONS: Among a diverse urban population, patients with DGE often carry multiple comorbid conditions that serve as risk factors for the development of gastroparesis, including prescriptions for narcotic medications. Greater numbers of these comorbid conditions are associated with more severe disease. Demographics are significantly associated with the etiology and severity of gastroparesis; in particular, African American patients are more likely to have diabetic gastroparesis than patients of other races.
Copyright: © Hellenic Society of Gastroenterology.
Keywords: Delayed gastric emptying; diabetes mellitus; narcotic medications
Conflict of interest statement
Conflict of Interest: None
References
- J Biomed Inform. 2009 Apr;42(2):377-81 - PubMed
- Am J Gastroenterol. 2013 Jan;108(1):18-37; quiz 38 - PubMed
- Gastroenterol Clin North Am. 2015 Mar;44(1):59-68 - PubMed
- J Clin Gastroenterol. 1989 Dec;11(6):625-30 - PubMed
- Dig Dis Sci. 1998 Nov;43(11):2398-404 - PubMed
- Dig Dis Sci. 1998 Sep;43(9):1951-6 - PubMed
- Gastroenterology. 2011 Jan;140(1):101-15 - PubMed
- J Clin Endocrinol Metab. 2009 Jun;94(6):1853-78 - PubMed
- Clin Gastroenterol Hepatol. 2011 Dec;9(12):1056-64; quiz e133-4 - PubMed
- J Clin Pharmacol. 1998 Nov;38(11):1017-20 - PubMed
- Am J Gastroenterol. 2001 Jan;96(1):77-83 - PubMed
- J Clin Gastroenterol. 1990 Oct;12(5):505-12 - PubMed
- Dig Dis Sci. 2014 Nov;59(11):2656-65 - PubMed
- JAMA. 2013 Dec 25;310(24):2640-9 - PubMed
- Am J Surg. 1996 Jul;172(1):24-8 - PubMed
- Gut. 2003 Jul;52(7):966-70 - PubMed
- Clin Gastroenterol Hepatol. 2011 Jan;9(1):5-12; quiz e7 - PubMed
- Am J Public Health. 2014 Nov;104(11):2147-55 - PubMed
- Dig Dis Sci. 2002 Dec;47(12):2664-8 - PubMed
- Am J Gastroenterol. 1989 Sep;84(9):1069-75 - PubMed
- Diabetologia. 1989 Mar;32(3):151-9 - PubMed
- Parkinsonism Relat Disord. 2011 Jan;17(1):10-5 - PubMed
- J Rheumatol. 2010 Nov;37(11):2313-8 - PubMed
- Br J Clin Pharmacol. 1975 Dec;2(6):509-13 - PubMed
- Aliment Pharmacol Ther. 2017 Apr;45(7):883-898 - PubMed
- Gut. 1980 Sep;21(9):753-9 - PubMed
- Can J Gastroenterol. 2005 Mar;19(3):141-5 - PubMed
- Clin Gastroenterol Hepatol. 2008 Sep;6(9):988-92 - PubMed
- J Pediatr. 1997 Nov;131(5):751-4 - PubMed
- Gastroenterology. 2011 May;140(5):1575-85.e8 - PubMed
- Scand J Gastroenterol. 1993 May;28(5):427-32 - PubMed
- Gastroenterol Res Pract. 2009;2009:529802 - PubMed
- Aliment Pharmacol Ther. 2008 May;27(9):724-40 - PubMed
- Br J Pharmacol. 1986 Dec;89(4):627-33 - PubMed
- Neurogastroenterol Motil. 2012 Jul;24(7):597-603 - PubMed
- Am J Gastroenterol. 1987 Jan;82(1):29-35 - PubMed
- Gastroenterology. 2009 Apr;136(4):1225-33 - PubMed
- Gastroenterology. 2004 Nov;127(5):1592-622 - PubMed
- J Clin Gastroenterol. 2013 Oct;47(9):757-61 - PubMed
- Am J Gastroenterol. 2012 Jan;107(1):82-8 - PubMed
- J Neurol. 2006 Feb;253 Suppl 1:I3-9 - PubMed
- Am J Gastroenterol. 1997 Sep;92(9):1501-4 - PubMed
- Am J Gastroenterol. 2008 Mar;103(3):753-63 - PubMed
- Clin Gastroenterol Hepatol. 2019 Jul;17(8):1489-1499.e8 - PubMed
- Eur J Gastroenterol Hepatol. 1997 Sep;9(9):901-4 - PubMed
- Neurogastroenterol Motil. 2015 Nov;27(11):1657-66 - PubMed
- N Engl J Med. 2007 Feb 22;356(8):820-9 - PubMed
- J Clin Gastroenterol. 2010 Jul;44(6):402-6 - PubMed
- Diabetes Care. 2001 Jul;24(7):1264-9 - PubMed
- Obes Surg. 2006 Sep;16(9):1243-5 - PubMed
- Nat Clin Pract Gastroenterol Hepatol. 2007 Jun;4(6):336-46 - PubMed
- Diabetes Care. 1999 Mar;22(3):503-7 - PubMed
- J Gastroenterol Hepatol. 2007 Sep;22(9):1423-8 - PubMed
- Gastroenterology. 1989 Jan;96(1):110-5 - PubMed
- Gastroenterology. 2015 Aug;149(2):340-9.e2 - PubMed
Publication Types